ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Pulmonary Disease

Top Pulmonary Disease Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JORGE SANCHEZ-MASIQUES MD

Pulmonary Disease

30,683

$3.78M

3492
3268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 56%

$123
Average prescription price

Avg: $161

JUAN ACEVEDO-CRESPO M.D.

Pulmonary Disease

12,870

$1.7M

1764
1613 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

86%
prescriptions for brand name drugs

Avg: 56%

$132
Average prescription price

Avg: $161

ANDRES REDONDO MD

Pulmonary Disease

12,818

$1.89M

1606
1466 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 56%

$147
Average prescription price

Avg: $161

CARLOS SANTOS M.D.

Pulmonary Disease

12,703

$1.51M

754
629 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 56%

$119
Average prescription price

Avg: $161

MARIO MANGAS M.D.

Pulmonary Disease

11,858

$1.91M

874
823 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 56%

$161
Average prescription price

Avg: $161

BINA JAIN MD

Pulmonary Disease

11,402

$383K

436
323 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 56%

$34
Average prescription price

Avg: $161

MARIVIC VILLA M.D.

Pulmonary Disease

10,921

$1.02M

1041
951 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 56%

$94
Average prescription price

Avg: $161

DEEPAK PATEL MD

Pulmonary Disease

10,279

$722K

656
513 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 56%

$70
Average prescription price

Avg: $161

BHARAT DESAI MD

Pulmonary Disease

9,662

$486K

553
416 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 56%

$50
Average prescription price

Avg: $161

SHAKTI NARAIN MD

Pulmonary Disease

8,975

$778K

802
580 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 56%

$87
Average prescription price

Avg: $161

POONAM WARMAN MD PA

Pulmonary Disease

8,833

$449K

410
359 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 56%

$51
Average prescription price

Avg: $161

CORNELIUS SCANNELL MD

Pulmonary Disease

8,333

$403K

437
408 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 56%

$48
Average prescription price

Avg: $161

RICHARD RUTHERFORD MD

Pulmonary Disease

8,160

$1.15M

546
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 56%

$141
Average prescription price

Avg: $161

MARIO MAGCALAS MD

Pulmonary Disease

7,910

$1.85M

1095
933 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 56%

$233
Average prescription price

Avg: $161

RAMESH NAYYAR M.D.

Pulmonary Disease

7,725

$403K

365
286 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 56%

$52
Average prescription price

Avg: $161

HUGO GONZALEZ M.D.

Pulmonary Disease

7,214

$587K

407
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 56%

$81
Average prescription price

Avg: $161

WILLY CHUA MD

Pulmonary Disease

6,646

$778K

729
531 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 56%

$117
Average prescription price

Avg: $161

LEONARD COSMO MD

Pulmonary Disease

6,519

$573K

338
203 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 56%

$88
Average prescription price

Avg: $161

JOSE MARQUINA M.D., F.C.C.P.

Pulmonary Disease

6,409

$1.04M

746
673 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 56%

$163
Average prescription price

Avg: $161

MARK KUTNER M.D.

Pulmonary Disease

6,381

$501K

595
529 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 56%

$78
Average prescription price

Avg: $161

DOUGLAS WEINER M.D.

Pulmonary Disease

6,021

$585K

501
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 56%

$97
Average prescription price

Avg: $161

JUAN CEVALLOS MD

Pulmonary Disease

5,993

$1.11M

808
624 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 56%

$185
Average prescription price

Avg: $161

JOEL FRANKEL MD

Pulmonary Disease

5,941

$358K

427
382 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 56%

$60
Average prescription price

Avg: $161

DENNIS BASSETTI MD

Pulmonary Disease

5,932

$593K

577
477 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 56%

$100
Average prescription price

Avg: $161

CARLOS BARRERA M.D.

Pulmonary Disease

5,749

$537K

480
353 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 56%

$93
Average prescription price

Avg: $161

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank